Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Treatment Research Subcommittee.                    

*Date:*                         October 17, 2000.                    

*Time:*                         9 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW., Washington, DC 20004.                    

*Contact Person:*                         Kesinee Nimit, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.                    

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Health Services Research Subcommittee.                    

*Date:*                         October 17-18, 2000.                    

*Time:*                         9 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW., Washington, DC 20004.                    

*Contact Person:*                         Marina L. Volkov, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel Treatment Research.                    

*Date:*                         October 17, 2000.                    

*Time:*                         1 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW., Washington, DC 20004.                    

*Contact Person:*                         William C. Grace, Deputy Director, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2755.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Health Services Research.                    

*Date:*                         October 18, 2000.                    

*Time:*                         11 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW., Washington, DC 20004.                    

*Contact Person:*                         Kesinee Nimit, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.                    

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Medication Development Research Subcommittee.                    

*Date:*                         November 1-2, 2000.                    

*Time:*                         9 a.m. to 4 p.m.                              ( print page 58096)    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 22209.                    

*Contact Person:*                         Khursheed Asghar, Chief, Basic Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Cognitive Approaches to Addictive Processes.                    

*Date:*                         November 14-15, 2000.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Radisson Barcelo Hotel, 2121 P Street, NW., Washington, DC 20037.                    

*Contact Person:*                         Marina. L. Volkov, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.                    

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Training and Career Development Subcommittee.                    

*Date:*                         November 14-16, 2000.                    

*Time:*                         9:00 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 22209.                    

*Contact Person:*                         Mark Swieter, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Training and Career Development.                    

*Date:*                         November 16, 2000.                    

*Time:*                         3:00 p.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 22209.                    

*Contact Person:*                         Rita Liu, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Centers Review Committee.                    

*Date:*                         November 20-21, 2000.                    

*Time:*                         8:30 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington,  VA 22202.                    

*Contact Person:*                         Rita Liu, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Genetics and Consequences of Nicotine Addiction.                    

*Date:*                         November 21, 2000.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington,  VA 22202.                    

*Contact Person:*                         Rita Liu, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-24722 Filed 9-26-00; 8:45 am]

BILLING CODE 4140-01-M